Research Solutions Inc (OTCMKTS:RSSS) has announced some changes to its management. The company has decided to bring in former CEO of Elsevier, John Regazzi, and appoint him as one of the directors on the board. Mr. Regazzi has over 40-years of experience from all sectors of the STM Information Industry. He is considered amongst the pioneers of the industry and has experience of working in corporate, government and academic institutions.
RSSS caters to the needs of research institutions and organizations, by providing them with scientific technical and medical (STM) information, related to life sciences. The appointment of Mr. Regazzi to the board brings the total number of directors to 7, with 4 of them serving independently. Currently, he serves as the M.D. of Akoya Capital Partners, which is a private investment firm. Here he has had experience of managing the information services for the investment firm.
However, his most notable achievements have been serving as a professor and dean for Long Island University’s College of Information and Computer Science. He also served as CEO for the NYSE listed Reed Elsevier, which happens to be the largest publisher for journals and other research related content. Here Mr. Regazzi oversaw the expansion of the company’s electronic publishing portfolio. The program resulted in $1 billion in revenues for the company. His experience and extraordinary skills of turning companies around makes him the right choice for the post.
RSSS CEO, Peter Derycz, stated that his company is at a transition stage to become a digital solution for STM information. As the number of users for the platform starts to increase, the company needs someone with the right skills and knowledge to make the most of this expansion. Being an industry leader and having experience in the design and launch of such platforms, the company finds Mr. Regazzi as the right man for the job.
Research Solutions Inc (OTCMKTS:RSSS) completed the July 1 session after trading 64,442 shares in the market, to reach a close at $1.10, without reporting any change in the share value.
